Last Updated: November 16, 2026

Drug Price Trends for SM MICONAZOLE

« Back to Dashboard


Drug Price Trends for SM MICONAZOLE

Average Pharmacy Cost for SM MICONAZOLE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
SM MICONAZOLE 7 CREAM 49348-0530-77 0.12302 GM 2026-07-22
SM MICONAZOLE 2% TOPICAL CREAM 49348-0689-72 0.12171 GM 2026-07-22
SM MICONAZOLE 7 CREAM 49348-0530-77 0.12399 GM 2026-06-17
SM MICONAZOLE 2% TOPICAL CREAM 49348-0689-72 0.12165 GM 2026-06-17
SM MICONAZOLE 7 CREAM 49348-0530-77 0.12408 GM 2026-05-20
SM MICONAZOLE 2% TOPICAL CREAM 49348-0689-72 0.12507 GM 2026-05-20
SM MICONAZOLE 2% VAGINAL CREAM 49348-0872-77 0.12408 GM 2026-05-20
>Drug Name >NDC >Price/Unit ($) >Unit >Date
Last updated: February 13, 2026

What Is the Market Scope for SM Miconazole?

SM Miconazole is an antifungal agent used primarily for topical fungal infections. It is part of the broader azole class, with a significant presence in dermatological, gynecological, and systemic antifungal treatments. The drug targets conditions such as athlete's foot, jock itch, vaginal candidiasis, and other dermatomycoses.

The global antifungal market was valued at approximately $11.2 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 4.8% through 2030, reaching around $17.5 billion. Miconazole constitutes a significant portion of this market due to its widespread use and formulary presence.

What Are the Current Price Points and Market Dynamics?

Price Ranges

  • Brand-name formulations: $15–$30 per 30-gram tube or 10-20 capsules, depending on formulation and region.
  • Generic formulations: $5–$15 per unit in the U.S. market; prices are slightly lower in emerging markets.
  • OTC formulations: Often priced at $4–$10 for over-the-counter cream or suppository forms.

Market Trends

  • The proliferation of OTC Miconazole products has increased accessibility and reduced the need for prescriptions.
  • New topical formulations include gels, sprays, and powders, expanding the product portfolio.
  • Patent expirations for various formulations have intensified generic competition, driving prices downward.

Pricing Comparison

Region Brand-Name Miconazole Price Generic Miconazole Price
United States $20–$30 per 30g $5–$15 per 30g
Europe €12–€25 per tube €4–€10 per tube
Asia-Pacific $3–$8 per tube $1–$5 per tube

The pricing varies due to regulatory policies, patent statuses, and supply chain factors.

What Are the Regulatory and Patent Factors Influencing Market Price?

Patent Expiry and Generic Entry

  • Original formulations often held patents until 2015–2020.
  • Since patent expiration, multiple generics entered the market, reducing prices.
  • In the U.S., the last patents for topical miconazole products expired in 2020.

Regulatory Approvals

  • In the U.S., the FDA approved several generic formulations, facilitating price competition.
  • In Europe, EMEA (European Medicines Agency) approval standards streamline generic approvals, affecting pricing.

Impact on Market Access

  • OTC availability in many regions enhances volume sales but limits pricing flexibility.
  • Healthcare reimbursement schemes influence retail prices, particularly in Europe.

What Are Future Price Trends and Market Drivers?

Price Projections

  • The analgesic and antifungal markets are expected to see a moderate decline in average prices for generic Miconazole over the next five years, driven by increased competition.
  • In developed markets, prices could decrease by 10–15% due to competitive pressures.
  • In emerging markets, prices may stay stable or slightly increase due to supply chain and manufacturing costs.

Key Drivers

  • Expanding OTC and combination formulations increase market volume.
  • Consolidation among generic manufacturers might stabilize prices temporarily but generally leads to increased competition.
  • Patent cliffs for newer formulations could introduce more affordable options.

What Are the Risks to Price Stability?

  • Regulatory changes that simplify approval processes could accelerate generic entry.
  • Price controls instituted by governments, especially in Europe and Asia, could reduce margins.
  • Shifts toward novel antifungal agents with better efficacy or safety profiles might diminish demand for traditional miconazole formulations.

Key Takeaways

  • The global antifungal market is sizable and growing, with Miconazole holding a significant share.
  • Prices vary considerably based on region, formulation, and patent status, with generics dominating the lower end.
  • Patent expirations have led to increased market competition and declining prices.
  • Future trends suggest continued price erosion in developed markets, stabilized or slightly increased prices in emerging markets.
  • Regulatory policies, patent protections, and competitive dynamics are primary factors shaping market prices.

FAQs

1. How does patent expiry affect Miconazole prices?
Patent expiry allows generic manufacturers to enter the market, increasing competition and reducing prices.

2. Are OTC Miconazole products significantly cheaper than prescription versions?
Yes, OTC formulations generally cost less, driven by regulatory classification and absence of prescription requirements.

3. What regions have the highest Miconazole prices?
Developed regions such as North America and Western Europe tend to have higher prices due to healthcare system structures and patent protections.

4. How might emerging markets influence global Miconazole pricing?
Lower manufacturing and distribution costs in emerging markets could keep prices stable or lower, expanding access.

5. Are there upcoming patent protections that could affect prices?
Most patents for topical Miconazole formulations expired by 2020; ongoing efforts to patent new formulations could temporarily restrict generic entry.


References

  1. Grand View Research. "Antifungal Drugs Market Size, Share & Trends Analysis." (2023).
  2. U.S. Food and Drug Administration. "Approved Drug Products with Therapeutic Equivalence Evaluations," 2022.
  3. European Medicines Agency. "List of Approved Medicinal Products," 2023.
  4. IQVIA. "Global Market Analysis & Market Share Data," 2022.
  5. Statista. "Antifungal Market Revenue Forecast," 2022.[1][2][3][4][5]

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.